XML 29 R20.htm IDEA: XBRL DOCUMENT v3.23.1
BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Details)
3 Months Ended
Oct. 14, 2022
$ / shares
Jan. 12, 2022
USD ($)
shares
Mar. 31, 2023
USD ($)
$ / shares
shares
Mar. 31, 2022
USD ($)
shares
Dec. 31, 2022
$ / shares
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Conversion ratio 0.04        
Common stock, par value (in dollar per share) | $ / shares $ 0.0001   $ 0.0001   $ 0.0001
Impairment charges of long-lived assets     $ 0 $ 0  
Antidilutive securities excluded from computation of earnings per share (in shares) | shares     716,840 431,407  
Aggregate payments under ASCA   $ 2,000,000      
Purchase in-process research and development technology   1,500,000 $ 0 $ 1,500,000  
Issuance of equity securities, net   $ 500,000 $ 311,681    
Common Stock          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Issuance of equity securities, net (in shares) | shares   40,000 142,499    
Issuance of equity securities, net     $ 14